Compare FCBC & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FCBC | CERT |
|---|---|---|
| Founded | 1874 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Retail: Computer Software & Peripheral Equipment |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 810.9M | 860.9M |
| IPO Year | 1996 | 2020 |
| Metric | FCBC | CERT |
|---|---|---|
| Price | $43.14 | $6.23 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $11.67 |
| AVG Volume (30 Days) | 61.3K | ★ 3.0M |
| Earning Date | 04-28-2026 | 05-11-2026 |
| Dividend Yield | ★ 5.26% | N/A |
| EPS Growth | N/A | ★ 87.50 |
| EPS | ★ 2.65 | N/A |
| Revenue | N/A | ★ $418,838,000.00 |
| Revenue This Year | $12.28 | $4.18 |
| Revenue Next Year | $2.55 | $5.39 |
| P/E Ratio | $16.12 | ★ N/A |
| Revenue Growth | N/A | ★ 8.75 |
| 52 Week Low | $31.21 | $5.19 |
| 52 Week High | $44.36 | $13.88 |
| Indicator | FCBC | CERT |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 52.47 |
| Support Level | $42.14 | $6.04 |
| Resistance Level | $44.15 | $6.48 |
| Average True Range (ATR) | 0.98 | 0.29 |
| MACD | -0.10 | 0.05 |
| Stochastic Oscillator | 49.79 | 65.07 |
First Community Bankshares Inc is a financial holding company that provides commercial banking products and services. The company is engaged in providing demand deposit accounts, savings, and money market accounts, certificates of deposits; commercial, consumer, and real estate mortgage loans, and lines of credit; various credit card, debit card, and automated teller machine card services; corporate and personal trust services; investment management services and life, health, and property and casualty insurance products. The company's revenue is mainly derived from interest, fees, and commissions.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.